Alcyone Therapeutics’ $23 million Funding Round

Foley Hoag advised Alcyone Therapeutics on the deal.Alcyone Therapeutics, a Lowell, Massachusetts-based biotechnology company pioneering next-generation precision central nervous system (CNS) therapies, closed $23 million in funding…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now